Paratek Pharmaceuticals Inc

BROWN BROTHERS HARRIMAN & CO

Report date

6/30/2023

Quarter

2023 Q2

Filed

8/7/2023

Shares

287,902

Value ($000)

636

Weight

0.0%

2019 Q4 - 2023 Q2 (15 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q2	8/7/2023	636	0.0%	287,902	6/30/2023
2023 Q1	5/11/2023	731	0.0%	287,902	3/31/2023
2022 Q4	2/9/2023	538	0.0%	287,902	12/31/2022
2022 Q3	11/14/2022	740	0.0%	287,902	9/30/2022
2022 Q2	8/11/2022	556	0.0%	287,902	6/30/2022
2022 Q1	5/13/2022	855	0.0%	287,902	3/31/2022
2021 Q4	2/14/2022	1,293	0.0%	287,902	12/31/2021
2021 Q3	11/15/2021	1,399	0.0%	287,902	9/30/2021
2021 Q2	8/13/2021	1,963	0.0%	287,902	6/30/2021
2021 Q1	5/13/2021	2,033	0.0%	287,902	3/31/2021
2020 Q4	2/16/2021	1,802	0.0%	287,902	12/31/2020
2020 Q3	11/16/2020	1,558	0.0%	287,902	9/30/2020
2020 Q2	8/13/2020	1,503	0.0%	287,902	6/30/2020
2020 Q1	5/15/2020	907	0.0%	287,902	3/31/2020
2019 Q4	2/14/2020	1,160	0.0%	287,902	12/31/2019